We are live on ! Find out more
CSC

Caldwell Sutter Capital Portfolio holdings

AUM $246M
1-Year Est. Return 23.62%
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
+23.62%
3 Year Est. Return
+65.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$318K
Cap. Flow
+$3.46M
Cap. Flow %
1.61%
Top 10 Hldgs %
22%
Holding
930
New
23
Increased
123
Reduced
156
Closed
32

Top Buys

Rank Stock Value
1
EQC
Equity Commonwealth
EQC
+$2.78M
2
AAPL icon
Apple
AAPL
+$459K
3
WM icon
Waste Management
WM
+$441K
4
V icon
Visa
V
+$331K
5
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$290K

Top Sells

Rank Stock Value
1
KNTK icon
Kinetik
KNTK
+$689K
2
ORCL icon
Oracle
ORCL
+$400K
3
DVN icon
Devon Energy
DVN
+$284K
4
COST icon
Costco
COST
+$238K
5
PFE icon
Pfizer
PFE
+$231K

Sector Composition

Rank Sector Weight
1 Financials 23.7%
2 Technology 12.63%
3 Industrials 11.97%
4 Consumer Staples 7.48%
5 Energy 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATI icon
626
ATI
ATI
$24.1B
$5.5K ﹤0.01%
100
– –
EWA icon
627
iShares MSCI Australia ETF
EWA
$1.38B
$5.34K ﹤0.01%
224
-274
-55% -$7.05K
IBKR icon
628
Interactive Brokers
IBKR
$38.7B
$5.3K ﹤0.01%
120
– –
VLO icon
629
Valero Energy
VLO
$89.8B
$5.27K ﹤0.01%
43
+9
+26% +$1.2K
ACH
630
Accendra Health
ACH
$252M
$5.23K ﹤0.01%
400
– –
TPR icon
631
Tapestry
TPR
$30.1B
$5.23K ﹤0.01%
80
– –
BIIB icon
632
Biogen
BIIB
$31.2B
$5.2K ﹤0.01%
34
– –
ROP icon
633
Roper Technologies
ROP
$40.4B
$5.2K ﹤0.01%
10
– –
RELX icon
634
RELX
RELX
$67B
$5.18K ﹤0.01%
114
– –
RARE icon
635
Ultragenyx Pharmaceutical
RARE
$2.5B
$5.17K ﹤0.01%
123
– –
CF icon
636
CF Industries
CF
$19.5B
$5.12K ﹤0.01%
60
– –
VGT icon
637
Vanguard Information Technology ETF
VGT
$134B
$4.97K ﹤0.01%
64
-392
-86% -$30.1K
AIG icon
638
American International
AIG
$42.7B
$4.88K ﹤0.01%
67
– –
XBI icon
639
State Street SPDR S&P Biotech ETF
XBI
$9.97B
$4.77K ﹤0.01%
53
– –
BP icon
640
BP
BP
$112B
$4.76K ﹤0.01%
161
– –
LYB icon
641
LyondellBasell Industries
LYB
$19.5B
$4.75K ﹤0.01%
64
– –
EWC icon
642
iShares MSCI Canada ETF
EWC
$6.12B
$4.67K ﹤0.01%
116
-301
-72% -$12.5K
ENSG icon
643
The Ensign Group
ENSG
$10.6B
$4.65K ﹤0.01%
35
– –
BTI icon
644
British American Tobacco
BTI
$136B
$4.65K ﹤0.01%
128
– –
VSS icon
645
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11B
$4.58K ﹤0.01%
40
– –
PSK icon
646
State Street SPDR ICE Preferred Securities ETF
PSK
$689M
$4.55K ﹤0.01%
138
– –
IGLB icon
647
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.63B
$4.54K ﹤0.01%
92
– –
GTX icon
648
Garrett Motion
GTX
$5.42B
$4.51K ﹤0.01%
500
– –
MPT
649
Medical Properties Trust
MPT
$2.88B
$4.47K ﹤0.01%
1,131
+18
+2% +$81
CNI icon
650
Canadian National Railway
CNI
$78.2B
$4.47K ﹤0.01%
44
– –
24 25
26
27 28

Similar funds

RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
HA
Hanover Advisors Seneca, South Carolina $246M AUM 12.74% 1-Year Est. Return
DB
Dravo Bay Rehoboth Beach, Delaware $246M AUM 15.09% 1-Year Est. Return
PPA
Pilgrim Partners Asia Singapore $246M AUM
HWM
HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Caldwell Sutter Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Caldwell Sutter Capital held 930 positions worth $215M, up 0.15% from $215M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Caldwell Sutter Capital's Q4 2024 filing shows 23 new, 123 increased, 156 reduced and 32 closed positions. Its largest new stake was BRAINSTORM CELL THERAPUTC: 157,009 shares worth $0. The largest sale was Kinetik, an estimated $689K.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Caldwell Sutter Capital's largest Q4 2024 buy was BRAINSTORM CELL THERAPUTC: 157,009 shares worth $0.
  • Caldwell Sutter Capital added most to Equity Commonwealth in Q4 2024, an estimated $2.78M increase.
  • Caldwell Sutter Capital's biggest Q4 2024 reduction was Kinetik, cutting an estimated $689K.
  • Caldwell Sutter Capital fully exited Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares in Q4 2024, selling an estimated $106K.
  • Caldwell Sutter Capital's ten largest holdings make up 22% of its $215M portfolio in Q4 2024.
  • Caldwell Sutter Capital opened 23 new positions and closed 32 in Q4 2024.
  • Caldwell Sutter Capital's portfolio value rose 0.15% quarter-over-quarter to $215M.

Based on Caldwell Sutter Capital's 13F filing for Q4 2024, filed 21 Jan 2025.